Orphenadrine Citrate, Aspirin And Caffeine Tablet
Product Images NDC 71993-304

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate, Aspirin And Caffeine (NDC 71993-304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atland Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Capture)

This is a description of a medication called "Orphenadrine Citrate, Aspirin and Caffeine Tablets USP". Each tablet contains 25mg/ 385mg/ 30mg. The usual adult dosage is one to two tablets three to four times a day, and additional literature is available. The tablets come in a bulk package of 607, and should be kept out of reach of children in a light-resistant container. The medication is manufactured for AT L AN D PHARMACEUTICALS and should be stored below 30 degrees Celsius. There are also measurements listed as 2.0000" and R0.1250", but their purpose is not clear.*

FDA Label Image

Structure (Structure1)

This text seems to describe a chemical compound with the molecular formula C,gH,NO*C.HO, and a molecular weight of 461.51. The number 1823 is not related to the description and may be an unrelated error.*

FDA Label Image

Structure1 (Structure2)

FDA Label Image

Structure2 (Structure3)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.